Skip to main content
Blog

Live healthier, stronger and sharper for longer

Short, frequent pieces on what changed in the science of ageing well — and our research library holds the deep dives.

Showing 7 of 513 posts Clear filters
Tirzepatide vs Semaglutide: Decoding Their
Peptides
TIRZEPATIDESEMAGLUTIDELONGEVITY

Tirzepatide vs Semaglutide: Decoding Their

A deep dive into tirzepatide vs semaglutide, comparing their mechanisms and clinical evidence for promoting healthspan and longevity.

Aug 2, 202612 min
Longevity Research Roundup: Interventions &
Research & News
GLP-1epigeneticsresistance training

Longevity Research Roundup: Interventions &

This August, we delve into new human data on GLP-1s, resistance training, novel geroprotectors, and nuanced takes on NAD+ supplementation.

Aug 1, 20269 min
Longevity Research Roundup: Unpacking Key
Research & News
GLP-1NAD+epigenetics

Longevity Research Roundup: Unpacking Key

This week's roundup dissects pivotal longevity research, offering actionable takeaways on cardiovascular health, biological age, and inflammation.

Jul 30, 20269 min
Longevity Research Roundup: Epigenetic Clues
Research & News
EpigeneticsMetabolic HealthGLP-1

Longevity Research Roundup: Epigenetic Clues

This week, we're dissecting epigenetic shifts from semaglutide, revolutionary proteomic ageing maps, and novel oral GLP-1s. Plus, creatine's surprising immune boost.

Jul 30, 20269 min
Longevity Research Roundup: Molecular Clues
Research & News
longevityexerciseGLP-1

Longevity Research Roundup: Molecular Clues

This week's roundup covers new findings on GLP-1s, senolytics, diet, and exercise, offering actionable insights for extending healthspan.

Jul 30, 20269 min
Longevity Research Roundup: New Measures &
Research & News
biological agemetabolic healthgut microbiome

Longevity Research Roundup: New Measures &

July's longevity research saw advances in biological ageing measurement, the gut microbiome's role, GLP-1 insights, and metabolic control for longer healthspan.

Jul 30, 20269 min
GLP-1 Drugs Beyond Weight Loss: The Longevity Signal Nobody Expected
Metabolic Health
GLP-1Metabolic HealthCardiovascular

GLP-1 Drugs Beyond Weight Loss: The Longevity Signal Nobody Expected

New cardiovascular, kidney and cognitive outcome data is reframing GLP-1 receptor agonists as potential healthspan drugs, not just appetite suppressants.

Jun 3, 20267 min

Wondering where to start?

Two minutes, no blood test, no sign-up — find out how you are actually ageing, and what to do about it.

The Sunday briefing

One email a week: what changed in the evidence, what it means for the markers you track, and the occasional thing worth stopping. No spam, unsubscribe anytime.